Evidence in preclinical models demonstrates that genes other than APP being in three-copies modifies aspects of DSAD, such as cognition and amyloid-β load [68, 1, 47], but more work is required to understand how the molecular processes of AD are altered by trisomy 21 in the brain of people with DS. Here, APP is linked to Dravet syndrome.